Anti-Cachectic Effect of Clarithromycin for Patients with Unresectable Non-Small Cell Lung Cancer

We have previously reported that long-term treatment with clarithromycin (CAM) increased the median survival of patients with non-small cell lung cancer, and improved various clinical parameters in th